Literature DB >> 11118374

Role of M protein aggregation in defective assembly of temperature-sensitive M protein mutants of vesicular stomatitis virus.

E A Flood1, M O McKenzie, D S Lyles.   

Abstract

The goal of these experiments was to determine the steps in virus assembly that are defective at the nonpermissive temperature in temperature-sensitive (ts) matrix (M) protein mutants of vesicular stomatitis virus. It has been proposed that mutations in M protein either reduce the binding affinity for nucleocapsids or lead to aggregation, reducing the amount of M protein available for virus assembly. Cytosolic or membrane-derived M proteins from wild-type VSV and two ts M protein mutant viruses, tsM301 and tsO23, as well as a revertant of tsO23 virus, O23R1, were analyzed for binding to nucleocapsid-M protein (NCM) complexes and for M protein aggregation. The experiments presented here showed that ts M proteins synthesized at the nonpermissive temperature were capable of binding to nucleocapsids and that aggregation of ts M proteins did not reduce the amount of soluble M protein below the amount required for assembly of the O23R1 virus. Instead, the most pronounced defect in ts M proteins was in the ability of membrane-derived M proteins to be solubilized in the presence of the detergent Triton X-100. It is proposed that this detergent-insoluble form of M protein interferes with a step necessary to initiate assembly of NCM complexes. A similar detergent, Triton X-114, caused aggregation of membrane-derived wild-type M protein, disproving an earlier proposal that membrane-derived M protein behaves like an integral membrane protein in the presence of Triton X-114. Aggregation of wild-type M protein in the presence of Triton X-100 could be induced by incubation at 37 degrees C with a high-molecular-weight fraction isolated from uninfected cells by sucrose gradient centrifugation. These results implicate host components in inducing M protein aggregation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118374     DOI: 10.1006/viro.2000.0675

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction.

Authors:  John H Connor; Margie O McKenzie; Douglas S Lyles
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.

Authors:  Valérie Janelle; Frédérick Brassard; Pascal Lapierre; Alain Lamarre; Laurent Poliquin
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

3.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.

Authors:  Maryam Ahmed; Margie O McKenzie; Shelby Puckett; Michael Hojnacki; Laurent Poliquin; Douglas S Lyles
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Vesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsids.

Authors:  Brooke Dancho; Margie O McKenzie; John H Connor; Douglas S Lyles
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.